Target intelligence / Profile preview

Vitamin K-dependent clotting factors (None)

Target
None
Molecular classification
Enzyme, Protein, Other
01

Overview

Vitamin K-dependent clotting factors are a group of plasma proteins whose biological activity relies on a unique vitamin K-dependent post-translational γ-carboxylation of specific glutamate residues, enabling them to bind calcium ions—a requirement for proper coagulation cascade function. This group includes procoagulant factors II (prothrombin), VII, IX, and X, as well as anticoagulant proteins C, S, and Z. Deficiency or inhibition of vitamin K leads to production of non-functional, non-activated forms of these clotting factors, resulting in bleeding disorders, while pharmacologic inhibition is the basis for oral anticoagulant therapy. They are synthesized primarily in the liver, and their deficiency or dysfunction can have significant clinical implications.

Other names
Vitamin K-dependent coagulation factorVKD clotting factorProthrombin (Factor II)Coagulation factor VIICoagulation factor IXCoagulation factor XProtein CProtein SProtein Z
02

Mechanism of action

Inhibition of vitamin K epoxide reductase (VKOR) by antagonists, preventing proper γ-carboxylation of glutamic acid residues, resulting in non-functional clotting factors

03

Biological functions

Blood coagulation/hemostasisAnticoagulationCalcium ion bindingRegulation of clotting cascade
04

Disease associations

Cardiovascular disease (thrombosis, embolism, bleeding disorders due to deficiency or inhibition)Other (Vitamin K deficiency can cause coagulation defects)
05

Safety considerations

Risk of hemorrhage/bleeding with excessive anticoagulation (from VK antagonists)Vitamin K deficiency in liver disease leads to bleeding riskVariation in vitamin K dietary intake can affect drug efficacy
06

Interacting drugs

Warfarin

3 more in the full profile.

07

Biomarkers

Prothrombin time (PT)International Normalized Ratio (INR)Levels of individual factors (II, VII, IX, X)Des-γ-carboxyprothrombin (DCP)

Beyond the preview

Go deeper on Vitamin K-dependent clotting factors (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitamin K-dependent clotting factors (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call